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Abstract
Objective. The aims of this studywere to: (1) use local health data to examine potentially preventable hospitalisations
(PPHs) as a proportion of total hospital separations and estimated costs to a large regional hospital in northern Queensland,
including differences associated with Indigenous status; and (2) identify priority conditions and discuss issues related to
strategic local primary health intervention.
Methods. Across-sectional analysiswas conductedusingQueenslandHospitalAdmittedPatientDataCollectiondata
(July 2012–June 2014) restricted to 51 087 separations generated by 29 485 local residents. PPHs were identified from the
International Statistical Classification of Diseases and Related Health Problems 10th Revision Australian Modification
(ICD-10-AM) and procedure codes using National Healthcare Agreement definitions. Age-standardised separation rates
werecalculatedusingAustralian2001 referencepopulationandassociatedeconomiccostswereestimatedusingAustralian-
refined diagnosis related groups.
Results. Eleven per cent (n = 5488) of all hospital separations were classified as PPH, and most were for common
chronic (n= 2486; 45.3%) and acute (n= 2845; 51.8%) conditions. Because many acute presentations reflect chronic
underlying disease, chronic conditions account for up to 76.5% of all PPHs. Age-standardised PPH rates were 3.4-fold
higher for Indigenous than non-Indigenous people. Associated 2-year costs were AU$32.7million, which was 10.7%
of estimated total health care expenditure for hospital separations, and were higher for Indigenous (14.9%) than non-
Indigenous (9.7%) people.
Conclusions. High hospitalisation rates and costs for common preventable chronic conditions represent
opportunities for primary healthcare interventions. In particular, community-level health services need to be more
responsive to the needs of local Indigenous families.
What is known about the topic? PPH rates are used as a measure of timely access to quality primary health care, and
are incrementally higher in regional and remote areas than in major cities. Investment in primary healthcare services has
been shown to significantly reduce costs associated with avoidable hospitalisations.
What does this paper add? This study used local health data to identify the most common PPH conditions presenting
to a large regional hospital in northern Queensland, including estimation of costs and differences associated with
Indigenous status. Recommendations are made to strengthen primary healthcare and reduce hospital-related costs.
What are the implications for practitioners? Interventions to address high PPH rates should be tailored to meet the
needs of the local population. Primary health strategies targeting common chronic conditions provide the greatest
opportunity to reduce avoidable hospitalisations and costs in this regional area. Investment in collaborative, evidence-
based interventions is recommended and justified, especially for Indigenous Australians.
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Introduction
Regional and remote hospitals have high rates of admission
for conditions that should have been managed with timely
access to quality primary and community health services.1,2
Australia’s National Healthcare Agreement defines these admis-
sions as potentially preventable hospitalisations (PPHs).3
Although debate remains around PPH definitions,4 the Austra-
lian Institute of Health and Welfare (AIHW) routinely collects
and analyses PPH data (sourced from hospital separation diag-
nosis and procedure codes) as a component of the National
Health Performance Framework to monitor the quality and
effectiveness of these services.
The PPH data are broadly classified into three types of
conditions: vaccine preventable, chronic health and acute med-
ical. The most recent AIHW report for 2014–15 found 493 347
PPHs were recorded in Australian public hospitals, accounting
for 8.2% of all separations.5 Rates per 1000 population remain
incrementally higher in regional (inner = 25.7; outer = 29.3) and
remote areas (remote = 39.8; very remote = 59.1) than in major
cities (23.7).5 The reason people living in regional and remote
areas have higher PPH rates is a complex issue, but three
factors are likely to contribute significantly: (1) higher levels
of socioeconomic disadvantage;6,7 (2) difficulty accessing
health services;8,9 and (3) a higher burden of disease and
comorbidities.10–14
Since 2006, the Australian Health Ministers’ Advisory
Council has produced biennial reports against the Aboriginal
and Torres Strait Islander Health Performance Framework.
Over this time period, results have remained fairly consistent
despite various improvements to coding rules. The most recent
of these reports15 found the rate of PPH for Aboriginal and
Torres Strait Islander people is threefold higher than for non-
Indigenous Australians, and this disparity generally increases
with age and remoteness. The report indicates these rates likely
reflect higher underlying disease burden, limited access to early
detection and management of common chronic conditions and
limited non-hospital alternatives in rural and remote areas.15
This is supported, in part, by a recent Northern Territory study
of 14 184 people living in remote Indigenous communities over
the period 2002–11,16 which found that higher primary health-
care utilisation was associated with a 60–85% reduction in
common chronic PPH, and every AU$1 invested in primary
health could produce savings of AU$3.95–11.75 in hospital
costs, in addition to other health benefits for individuals.
The relative paucity of primary and other community health
services in regional and remote areas contributes significantly to
high PPH rates, with local hospitals becoming the default service
provider.17 For example, factors such as adequate physician
supply, long-term physician–patient relationships and general
practitioner (GP) management plans have all been found to be
important for reducing PPHs.18 A recent report from the Grattan
Institute identified northern Queensland as a ‘hot spot’ for PPHs,
with rates at least 50% higher than the state average in every year
for a decade.19 The authors of that report recommend that
geographical areas such as these represent persistent and costly
health inequality, and should be prioritised for state and federal
government investment to improve primary and other health
services. The authors also recommendusing local data to assist in
identifying the health priorities of local communities and in
developing, testing and evaluating tailored interventions over
time.19 The federal government is currently trialling the intro-
duction of ‘health care homes’ throughout Australia,20 the
purpose of which is to strengthen the role of general practices
and Aboriginal Community Controlled Health Services
(ACCHSs) as the central care provider (rather than the hospital)
by providing continuity of care for people with chronic and
complex conditions. In addition to improvements in access, care
processes and patient experience, it is hoped that this initiative
will reduce unnecessary hospitalisations, including PPHs.
The purpose of the present study was to use local admissions
data from a large regional tertiary care hospital in far north
Queensland to examine PPHs (and estimated costs) as a propor-
tion of total hospital separations and by Indigenous status. We
also identify opportunities for local primary health services to
reduce hospitalisations and discuss issues related to strategic
intervention.
Methods
Study setting and population
Located in northern Queensland, Australia, the large public
hospital provides tertiary care for over 275 000people.Although
the hospital services people living in very remote areas, it
primarily caters for the large regional population in the surround-
ing 10 Statistical Local Areas (SLAs). Approximately 68 867
hospital separations were recorded between 1 July 2012 and 30
June 2014. Of these, 74.2% (51 087) were generated by people
living in the 10 SLAs, and the results of the present study are
based on these separations. The 10 SLAs ‘map’ to two larger
Local Government Area (LGA) boundaries (Cairns (LGA/
32070) and Yarrabah (LGA37600)). The Far North Queensland
Human Research Ethics Committee approved the present study
(HREC/13/QCH/131-880) and data were provided by Queens-
land Health.
Demographic and other factors of interest
Factors of interest were determined from raw Queensland Hos-
pital Admitted Patient Data Collection (QHAPDC) data, includ-
ing gender, age, Indigenous status, SLA, medical or unit record
number (URN), length of stay (LOS), admission and discharge
dates andfinal primaryand secondarydiagnoses. Socioeconomic
disadvantage for each SLA was measured using the Index of
Relative Socioeconomic Disadvantage (IRSD) calculated by the
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Australian Bureau of Statistics21 and based on 2011 Census
data (http://www.abs.gov.au/AUSSTATS/abs@.nsf/Details-
Page/2033.0.55.0012011?OpenDocument, accessed 4 February
2018). The IRSD was used because it provides a broad measure
of disadvantage by ranking areas according to a range of social
and economic conditions reported at the individual and house-
hold level within each SLA. Some of the factors of interest
when measuring IRSD include income, educational attainment,
unemployment and unskilled occupations. Lower IRSD scores
indicate areas with greater disadvantage and higher scores
indicate areas with least disadvantage.
Potentially preventable hospitalisations
PPHs were identified from discharge diagnosis codes using
International Statistical Classification of Diseases and Related
Health Problems 10th Revision Australian Modification (ICD-
10-AM)22 and relevant procedure codes using National Health-
care Agreement definitions.23
Estimation of costs
Costs associated with PPHs were estimated using Australian-
refined diagnosis-related groups (AR-DRG). The AR-DRGs are
sourced from the AIHW National Hospital Morbidity Database
(NHMD) with diagnostic groupings based upon ICD-10-AM
classifications. According to the AIHW, AR-DRG is an Austra-
lian admitted patient classification system that provides a clin-
ically meaningful way of relating patient casemix to resources
required by the hospital.24 National average costs for each
AR-DRG were provided by the Independent Hospital Pricing
Authority (IHPA), including both total cost and disaggregated
intomain procedures and average LOS. This study selected costs
relating to the financial year 2013–14 in order to align with the
hospital’s admission data.25 These national average total costs
forAR-DRGswere then converted into an ‘average per day cost’
by dividing the total cost by average LOS. To estimate hospital
costs, this average per day cost wasmultiplied by the actual LOS
taken from hospital records for each acute PPH patient admis-
sion. Total costs for each PPH andmedian patient cost, driven by
LOS, were estimated.
Statistical analysis
Analyseswere performedwith STATA13.1 (StataCorp,College
Station, TX, USA). Records were linked to individuals using the
unique URN and the number of separations per person was
calculated as the number of separations per URN.
Crude rates per 100 000populationwere calculatedusing two
financial years of hospital separation data combined (1 July
2012–30 June 2014) and two financial years of population data
for the same period. A 2-year period of hospitalisations was
selected to reduce the effect of annual variability in separation
rates. The population data were the estimated residential popu-
lation sourced from the Queensland Regional Database main-
tained by the Queensland Government Statistician’s Office
(http://www.qgso.qld.gov.au/products/tables/qld-regional-da-
tabase/index.php; accessed 15 April 2015). Data were extracted
in 5-year age groups by Indigenous status for Cairns (LGA/
32070) and Yarrabah (LGA37600).
Age distributions for Indigenous and non-Indigenous separa-
tions were dissimilar. To enable comparisons of separation rates
between groups, crude rates were directly age standardised26 to
the 30 June 2001 Australian standard population maintained by
Australian Bureau of Statistics.27
Table 1. Characteristics of 51 087 hospital separations, according to potentially preventable hospitalisations
(PPHs) from 1 July 2012 to 30 June 2014, local residents only
Data are given as n (%). IRSD, Index of Relative Socioeconomic Disadvantage
PPH Non-PPH Total
Total hospital separations 5488 (10.7) 45 599 (89.3) 51 087 (100.0)
Gender
Male 2653 (48.3) 23 871 (52.3) 26 524 (51.9)
Female 2835 (51.7) 21 728 (47.7) 24 563 (48.1)
Indigenous status
Indigenous 1420 (25.9) 7961 (17.5) 9381 (18.4)
Non-Indigenous 4068 (74.1) 37 638 (82.5) 41 706 (81.6)
Age group (years)
Infants and toddlers (0–4) 541 (9.9) 6849 (15.0) 7390 (14.5)
Children and early teens (5–14) 423 (7.7) 2278 (5.0) 2701 (5.3)
Teenagers and young adults (15–24) 429 (7.8) 3795 (8.3) 4224 (8.3)
Adults (25–44) 930 (16.9) 10 180 (22.3) 11 110 (21.7)
Middle-aged adults (45–64) 1347 (24.5) 11 784 (25.8) 13 131 (25.7)
Senior adults (65–84) 1412 (25.7) 8735 (19.2) 10 147 (19.9)
Elderly (85) 406 (7.4) 1978 (4.3) 2384 (4.7)
Arrived by ambulance 2633 (58.3) 13 515 (51.3) 16 148 (52.3)
IRSD
Quartile 1 (most disadvantaged) 1327 (24.2) 9567 (21.0) 10 894 (21.3)
Quartile 2 2355 (42.9) 19 873 (43.6) 22 228 (43.5)
Quartile 3 1806 (32.9) 16 159 (35.4) 17 965 (35.2)
Quartile 4 (least disadvantaged) 0 (0.0) 0 (0.0) 0 (0.0)
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Each hospitalisation in the dataset had an allocated diagnosis-
related group (DRG). To estimate the cost of PPHs, each
hospitalisation was allocated a monetary figure based on the
corresponding DRG. These amounts were then aggregated
based on PPH categories and the total and median costs were
calculated by Indigenous status.
Results
Potentially preventable hospitalisations
In the two financial years 2012–14, there were approximately
51 087 separations generated by 29 485 people (Table 1). Of
these separations, 10.7% (5488) were classified as potentially
preventable. Half of all PPHs were for women (51.7%)
and approximately one-third were for those aged 65 years
(33.1%). Indigenous people represented 25.9% of all PPHs
despite accounting for only 12.9% of the Cairns and Yarrabah
LGA populations. Potentially preventable hospitalisation rates
were substantially higher for Indigenous people across 5-year
age groups, particularly in older age groups (Fig. 1).
Most PPHs were for chronic (45.3%) and acute (51.8%)
conditions (Table 2). Most chronic conditions (93.2%) were
for chronic obstructive pulmonary disease (COPD; n = 640;
25.7%), diabetes complications (n= 432; 17.4%), congestive
cardiac failure (CCF; n= 375; 15.1%), angina (n= 322;
13.0%), iron-deficiency anaemia (n= 289; 11.6%) and asthma
(n= 258l; 10.4%). Most acute conditions (95.8%) were for
urinary tract infections (UTI; n= 976; 34.3%), convulsions
(n= 575; 20.2%), ear, nose, throat (ENT) infections (n = 438;
15.4%), dental conditions (n= 353; 12.4%), cellulitis (n = 257;
9.0%) and gangrene (n= 126; 4.4%).
The top four conditions for Indigenous people were UTIs
(n= 201; 14.2%), convulsions (n= 182; 12.8%), diabetes com-
plications (n= 178; 12.5%) andCOPD (n= 156; 11.0%). The top
four conditions for non-Indigenous people were UTIs (n = 775;
19.1%), COPD (n= 484; 11.9%), convulsions (n= 393; 9.7%)
and ENT infections (n= 355; 8.7%).
Age-standardised rate ratios
Age-standardised PPH rates were higher for Indigenous people
across all PPH categories (Table 2). Overall, Indigenous people
were 3.5-fold more likely to have a PPH than non-Indigenous
people (age-standardised rate 3.4; 95% confidence interval (CI)
3.2–3.6). Age-standardised rates for Indigenous people were
eightfold higher for vaccine-preventable PPHs (7.8; 95% CI
5.6–10.6)], fourfold higher for chronic PPH (4.1; 95% CI 3.7-
–4.5), almost threefold higher for acute PPH (2.7; 95% CI
2.4–3.0) and nearly eightfold higher for diabetes complications
(7.7; 95% CI 6.2–9.4).
Age groups
Acute conditions were highest among younger age groups and
generally decreased with age, whereas chronic conditions were
lowest among younger age groups and increased with age.
Vaccine-preventable conditions were fairly uniform across age
groups. The pattern of PPH distribution across the lifespan was
similar by Indigenous status except that the intersection point
where chronic conditions start to outnumber acute conditions
occurred one decade earlier for Indigenous people (41–50 years)
than non-Indigenous people (51–60 years; Fig. 2). Diabetes
complications appeared regularly in the top four PPH conditions
across the lifespan for Indigenous people and COPD appeared at
a younger age (Table 3).
Costs of PPH
All separations
Total PPH represented 5488 separations and an estimatedAU
$32.7million, which was 10.7% of total hospital separation
expenditure over the 2-year period (Table 4). The top three most
expensive PPHs, in terms of total cost for all separations, were
UTI (AU$4.9million), COPD (AU$4.9million) and diabetes
(AU$4.5million). Associated median costs (and median LOS)
per separation types were: AU$3542 (1 day) for UTI, AU$5627
(3 days) for COPD and AU$6332 (3 days) for diabetes.
Non-Indigenous separations
Total PPHs in the non-Indigenous population represented
4068 separations and AU$23.8million, which was 9.7% of total
hospital costs for this group. The top threemost expensive PPHs,
in terms of total cost for all separations, were UTI ($4.0million),
COPD ($3.8million) and CCF ($2.4million).
Indigenous separations
Total PPHs in the Indigenous population represented 1420
separations and AU$8.9million, which was 14.9% of total
hospital costs for this group. The top threemost expensive PPHs,
in terms of total cost for all separations, were diabetes ($2.2mil-
lion), COPD ($1.1million) and UTI ($1million). Overall, the
median cost per separation type tended to be slightly higher for
Indigenous people, with diabetes themost notable with amedian
cost (LOS) of AU$11 546 (3 days) for Indigenous people
compared with AU$4887 (2 days) for non-Indigenous people.
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Fig. 1. Potentially preventable hospitalisation (PPH) rates for 5488
hospital separations, by Indigenous status and 5-year age groups, from
1 July 2012 to 30 June 2014, local residents only.
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Discussion
Chronic and acute conditions accounted for 97% of all PPHs to
this large public hospital in regional north Queensland. Most
chronic conditions were for COPD, diabetes complications,
CCF, angina, iron-deficiency anaemia and asthma. Most acute
PPH conditions were for UTIs, convulsions, ENT infections,
dental conditions, cellulitis and gangrene.AlthoughUTIs, dental
conditions, cellulitis and gangrene present acutely, they often
reflect a chronic underlying condition, such as diabetes. If this
was taken into consideration, chronic conditions would account
for 76.5% of all PPHs. Age-standardised rates for Indigenous
people were consistently higher than those for non-Indigenous
people, with diabetes complications appearing regularly in the
top four PPH conditions across the lifespan and chronic condi-
tions such as COPD appearing at a younger age. The financial
costs associated with PPH were substantially higher for Indig-
enous people, and justify investment in strategic, collaborative,
evidence-basedprimaryhealth interventions aimedat addressing
health inequalities experienced in northern Queensland.
PPH rateswere found to be consistently higher for Indigenous
people across the lifespan. These findings are consistent with
a recent national report against the Aboriginal and Torres Strait
Islander Health Performance Framework28 that found these
disparities also generally increased with remoteness. A recent
Northern Territory study29 found PPH rates per 100 000 popu-
lation were 11 090 for Aboriginal people and 2779 for non-
Aboriginal people for the 8-year period from 1998–99 to
2005–06. These rates are somewhat higher than those observed
in the present study, but the Northern Territory study was
based on hospitalisation data for the entire Northern Territory
covering large areas considered to be remote or very remote, and
remoteness has been shown to be consistently associated with
higher PPH rates.5 We attempted to remove these geographical
differences by restricting the present study to only those people
considered local residents surrounding the hospital. Although
we observed relatively low rates of vaccine-preventable PPHs
in our population, the rate of these PPHs for Indigenous people
was nearly eightfold higher than for non-Indigenous people.
This is consistent with national reports.5 Aboriginal Medical
Services and other health services in the area have invested
considerable effort in recent years to improve historically low
vaccination rates. In addition to existing clinic-based vaccina-
tion, services have engaged in strategies including education
programs, outreach home visits and targeting of priority groups
within the community.
Aspects of primary healthcare that have been found to be
important for reducing PPH include adequate physician supply,
continuity of care,GPmanagement plans, subsidised community
health services and higher utilisation.2,16,30 A recent preliminary
report released for consultation on primary care services funded
through the Medicare Benefits Schedule found that funding for
urgent after-hours services in Queensland is far less in regional
and remote areas like Far North Queensland than urban areas
such as Brisbane.31 Although there appears to be broad agree-
ment that these types of services may increase access to primary
healthcare, their role in reducing PPH is currently undetermined.
Indeed, considerable concern exists among professional groups
that these services may undermine the quality and safety of
primary health through the provision of costly and fragmented
care often by underqualified medical practitioners.31–33
Four recent publications have reviewed available evidence
regarding primary health interventions and PPH, most of which
has been focused on chronic disease-specific approaches (e.g.
diabetes and COPD).2,18,30,34 Overall, evidence for specific
interventions to reduce PPHs is weak. Australian initiatives
show promise rather than conclusive evidence.30 The interna-
tional review of 49 reports from high-income countries conclud-
ed that strong primary care (adequate primary care physician
supply and continuity of care embodied in the ‘medical home’
approach, including self-management support as described in the
Wagner Chronic Care Model35) reduces avoidable hospitalisa-
tions for chronic conditions.18 The authors of that review also
found that there is currently a lack of evidence for other inter-
ventions, such as disease-specific management programs. Al-
though there are numerous examples of care coordination
programs in Australia, their effect on reducing PPH rates is
inconclusive and requires further investigation.2 A recent report
fromtheGrattan Institute identifying ‘hot spots’withpersistently
high PPH rates recommends developing, testing and evaluating
tailored interventions for local areas to address the health inequi-
ties that lead to higher PPH rates.19 The authors of that report
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include a collaborative approach in their strategy, whereby
primary health networks are supported financially and otherwise
by federal and state governments to lead targeted intervention
research with primary and other health services within their
jurisdiction. However, the federal government currently funds
primary healthcare and the state governments fund hospital care.
Consequently, there are likely to be considerable financial
challenges ahead in achieving the strategic development (and
sustained financing) of the innovative interventions required.
The present study has identified opportunities to reduce
PPHs in this large regional hospital in northern Queensland. We
found that 76.5% of all PPHs were either chronic conditions
(COPD, diabetes complications, CCF, angina, iron-deficiency
anaemia and asthma) or likely related acute conditions such
as UTIs, dental conditions, cellulitis and gangrene. As such, we
suggest targeting these specific conditions because they are
likely to be conducive to trials involving collaborative primary
healthcare interventions and potentially deliver the most cost
savings and individual benefit. One-third of all PPHs in the
present study were for people aged 65 years. Targeting pro-
grams at high-risk age groups is therefore justified. Several
promising projects are currently underway in the region aiming
to improve the integration of care for elderly people living with
complex conditions. The local region is not without other
strategies to address conditions favourable to primary healthcare
management, although historically many of these strategies
have been implemented without proper consideration for effec-
tive evaluation. The local public hospital currently provides
a suite of services that have been shown to reduce PPH for
specific conditions,19 including a specialist diabetes out-patient
clinic, physiotherapy and rehabilitation clinics for cardiac and
pulmonary conditions and nurse-led case management of
people with complex health needs. Initiatives such as the inte-
grated electronic medical record and telehealth have also been
evolving to enhance access, communication and continuity of
care between health services. However, the results of the
present study indicate that more could be done, especially for
Aboriginal and Torres Strait Islander people living in the region.
Initiatives to reduce PPHs specifically for Indigenous people
are still rare.30 Much of the work is performed by the local
Aboriginal Medical Services using Medicare Item 715 as remu-
neration for annual health checks.36 These are designed to
promote early detection, diagnosis and management of many
conditions associated with PPHs. There are also specific remu-
neration arrangements for GP management plans for chronic
diseases. Aboriginal Medical Services also initiate programs
targeting areas of high community need, although these are
often challenging for the organisation to fund and resource.
These initiatives may target specific health issues such as influ-
enzavaccination, diabetes, oral health and sexually transmissible
infections, or be focused on broader upstream issues such as
maternal and child health, social and emotional well-being
and alcohol and drug support. Future success in lowering
PPH rates is likely to involve collaborative design and imple-
mentation of multifactorial programs targeting the common
conditions and high-risk subgroups with complex needs identi-
fied in the present study. Programs should include: (1) early
detection, early treatment and symptom management; (2)
creation of supportive environments; (3) self-management
support; (4) service delivery and coordination; (5) local
liveability; (6) socioeconomic opportunity;37,38 and (7) respect-
ful, community-led collaboration.39
Key to lowering PPH rates in northern Queensland is likely
to be further development of primary healthcare services,
including Aboriginal Medical Services. A promising reform
in this area is the federal government’s introduction of ‘health
care homes’ throughout Australia. Clinicians from participating
primary healthcare services will become responsible for the
overall coordination of chronic disease management of their
patients, regardless of where the treatment occurs.20,40 In
exchange for this, practices will receive an annual complexi-
ty-based payment of betweenAU$591 andAU$1795per patient,
and a single grant to support training and establishment.20
Whether this model will work in rural and remote areas is
yet to be seen. Evidence from implementation studies of the
Medical Home in the US has demonstrated some improvement
in preventative care service delivery for people with chronic
conditions, although results are mixed and insufficient for
service provision (including accessibility and coordination
of care), clinical outcomes, in-patient utilisation41 and
patient experience.42 Diversity in the primary care setting has
challenged implementation of the Medical Home care model,
indicating a need for setting-specific approaches to address the
healthcare needs of distinctive population subgroups.
The present study has numerous strengths and also limita-
tions. Analysis was based on a 2-year QHAPDC dataset for
the major regional public hospital servicing a discrete area in
northern Queensland. The dataset was complete and analysis
was carefully restricted to local residents living in 10 SLAs
surrounding the hospital. However, the results are subject to
error inherent in any secondary administrative dataset. For
example, errors in defining the local population within SLAs
immediately around the hospital may have occurred from
incorrect information collected relating to residential postcode
and suburb. Similarly, PPHs used in our analyses were
defined using National Healthcare Agreement definitions.23
These include relevant ICD-10-AM discharge diagnosis and
procedure codes, both of which have been shown to have limited
accuracy.43,44
Somecontroversyexists as towhether currentPPHconditions
truly reflect hospitalisations that are potentially preventable. As
such, PPH definitions are frequently revised and are recom-
mended to be used as performance indicators only.4 In addition,
accuracy in identifying Indigenous status in Australian public
hospitals has been shown to vary by geographical location, with
only 93% of Indigenous and 98% of non-Indigenous separations
correctly identified in outer regional settings such as ours.45
Consequently, the true number of Indigenous separations in our
dataset and age-standardised estimates are likely to be higher
than reported here. The costing analysis was essentially a ‘top-
down’ approach using national average costs for AR-DRG and
applying to the hospital by adjusting for actual LOS. This is
appropriate for analysis at a population level. However, the
costs are approximations. A more refined method would be, for
example, a microcosting approach to directly access the
hospital’s medical and financial records to cost each acute
admission. However, this approach was not practicable, nor
deemed necessary, for this population-level analysis.
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Conclusion
The results of the present study suggest that opportunities exist
to improve local hospital and primary health services to reduce
hospitalisation for common preventable conditions in regional
north Queensland. In particular, community-level health ser-
vices need to bemore responsive to the needs of local Indigenous
families. Future research should be visionary and committed
to improvements over the long term. Initiatives need to involve
formal coordinated collaboration between primary health net-
works, Queensland Health and ACCHSs supported by secure
funding and other resources from federal and state governments.
Trialling and prospective evaluation of these initiatives would
provide timely evidence regarding efficiency and cost-effective-
ness for both local and national use.
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